A new study published in the International Journal of Obesity showed that cardio-cerebrovascular disease (CCVD) risk was significantly increased by sarcopenic obesity by a factor of two.
Reduced skeletal muscle mass and function combined with excess adiposity is known as sarcopenic obesity, and it has become a major public health problem. While obesity and sarcopenia are both known risk factors for negative health outcomes, their combined effects seem to be more harmful and synergistic.
There is growing evidence that sarcopenic obesity increases the risk of cardio-cerebrovascular illnesses and early death by causing systemic inflammation, insulin resistance, and vascular dysfunction. Developing focused preventative and treatment measures to lower morbidity and mortality in at-risk popu